PD-1/L1 immune checkpoint inhibitors for KRAS-mutant non-small cell lung cancer: a multicenter retrospective real-world study

Related articles

1. A Study on the Efficacy of Immune Checkpoint Inhibitors Combined with Chemotherapy in Patients with Oligometastatic Driver Gene-Negative Non-Small Cell Lung Cancer Undergoing Radiotherapy

   This article has 10 authors:

   1. Yang Liu
   2. Lingxiao Xie
   3. Jiaoyue Qu
   4. Quan Pan
   5. Zhao Yu
   6. Yin Yuan
   7. Chunyu Chang
   8. Hao Jiang
   9. Yuexin Yang
   10. Gengming Wang at

2. Efficacy and safety of different PD-1 inhibitors as first-line treatment for advanced or metastatic squamous non-small cell lung cancer: A retrospective real-world study

   This article has 4 authors:

   1. Mengjiao Fu
   2. Jingjing Qu
   3. Jianya Zhou
   4. Jianying Zhou

3. The Predictive efficacy of tumor mutational burden for immune Checkpoint Inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials

   This article has 7 authors:

   1. Min Ying
   2. Mengyu Hu
   3. Kegui Weng
   4. Yanyan Long
   5. Jing Chen
   6. Qianqian Lei
   7. Yongzhong Wu